|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 601 Pennsylvania Ave., NW |
Address2 | Ste. 700 |
City | Washington |
State | DC |
Zip Code | 20004 |
Country | USA |
3. Principal place of business (if different than line 2)
City | |
State | |
Zip Code | |
Country | |
|
5. Senate ID# 89177-12
|
||||||||
|
6. House ID# 366750000
|
TYPE OF REPORT | 8. Year | 2011 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date | |
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Lillian German, Director of Government Affairs |
Date | 05/09/2012 |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Issues related to healthcare reform implementation: Health Information Technology; ARRA Privacy and Security Rules; Generic Biologics; Importation of Prescription Drugs; Competitive Bidding; Home Infusion; Chronic Care Management; anit-PBM legislation, including disclosure of pricing and contracting information; healthcare delivery systems reforms, and cost containment.
H.R. 1 - American Recovery and Reinvestment Act of 2009; Title VIII Department of Labor, Health and Human Services, and Education and related agencies; Healthcare Research and Qualtiy and Title XIII - Helath Information Technology for Exonomic and Clinical Helaht Act or the HITECT Act; all sections.
HR 1321 and S 391 - Health Americans Act, all sections
HR 1548 - Pathway for Biosimiars Act, all sections
HR 3200 - America's Affordable Health Choices Act; all sections
Public Law 111-148 - Patient Protection and Affordable Care Act; all sections (formerly HR 3500, H Con Res. 254, S 1790)
Public Law 111-152 - Helath Care and Education Reconciliation Act of 2010, all health sections (formerly HR 4872 and S. Con Res. 13)
HR 979 - The FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act; all sections
HR 1041 - Fairness in Medicare Bidding Act (FIMBA); Section 2
HR 5 - Help Efficient, Accessible, Low Cost, Timely Healthcare Act of 2011, all sections
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Food & Drug Administration (FDA), Centers For Medicare and Medicaid Services (CMS), Health Resources & Services Administration (HRSA), Executive Office of the President (EOP), Congressional Budget Office (CBO)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Peter |
Harty |
|
|
|
Barbara |
Cosgriff |
|
|
|
Lillian |
German |
|
|
|
Jennifer |
Romans |
|
|
|
Ryan |
Sadler |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
Healthcare reform; healthcare regulations; Medicare part D; proposed antitrust exemptions for certain pharmacies; IVIG payments; Medicare demonstration projects for durable medical equipment; importation of prescription drugs; home infusion; disclosure of PBM information; changes to drug benefits offered under the FEHBP and increasing healthcare value; competitive bidding.
HR 574 and S 254 - Medicare Home Infusion Coverage Act; all sections
HR 1765 - To Amedn Title XVIII of the SSA with respect to payment for the furnishing of intravenous immune globulin (IVIG) in a patient's home for the treatment of primary immune deficiency diseases and to cover certain disposable pumps as durable medical equipment in place of non-disposable pumps under the Medicare program; all sections
HR 3962 - Affordable Care Act for All America Act; all sections
S 1796 - America's Health Future Act; sections 1001-2221
HR 3790 - To amend Title XVIII of the SSA to repeal the Medicare Competitive Acqusition program for durable medical equipment and prosthetics, orthotics and supplies (DMEPOS); all sections
Public Law 111-152 - Health Care and Education Reconciliation Act (formerly HR 4872); all sections
HR 1041 - Fairness in Medciare Bidding Act (FIMBA), section 2
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Centers For Medicare and Medicaid Services (CMS), Federal Trade Commission (FTC), Health & Human Services - Dept of (HHS), Executive Office of the President (EOP)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Peter |
Harty |
|
|
|
Barbara |
Cosgriff |
|
|
|
Jennifer |
Romans |
|
|
|
Lillian |
German |
|
|
|
Ryan |
Sadler |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code PHA
16. Specific lobbying issues
Healthcare reform implementation; antitrust exemptions for independent pharmacists; anti-PBM legislation, including disclosure of pricing and contracting information; mail order pharmacy; federal employee health benefits program.
HR 1 - American Recovery and Reinvestment Act of 2009; Title XIII - Health Information Technology for Economic and Clinical Health Act or the HITECH Act; all sections.
Public Law 111-152 - Health Care and Education REconciliation Act of 2010 (formerly HR 4872 and S. Con. Res 13); all health sections
HR 3790 = To Amend Title XVIII of the SSA to repeal the medicare Competitive Acquistion program for DMEPOS, all sections
HR 1041 - Fairness in Medicare Bidding Act (FIMBA); section 2
HR 979 - The FEHBP Drug Integrity, Transparency, and Cost Savings Act of 2011; all sections
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Centers For Medicare and Medicaid Services (CMS), Federal Trade Commission (FTC), Health & Human Services - Dept of (HHS), Office of Personnel Management (OPM)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Peter |
Harty |
|
|
|
Barbara |
Cosgriff |
|
|
|
Lillian |
German |
|
|
|
Jennifer |
Romans |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code POS
16. Specific lobbying issues
Issues related to proposals to limit mail delivery service by the United States Postal Service; postal reform
HR 1262 - Reform the Postal Service for the 21st Century Act; sections 3-13
HR 1351 - United States Postal Service Pension Obligation Recalculation and Restoration Act of 2011; all sections
S 353 - United States Postal Service Improvements Act of 2011; all sections
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Postal Rate Commission, Postal Regulatory Commission, U.S. Postal Service (USPS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Peter |
Harty |
|
|
|
Lillian |
German |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address | |
||||||
City | |
State | |
Zip Code | |
Country | |
21. Client new principal place of business (if different than line 20)
City | |
State | |
Zip Code | |
Country | |
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
5 |
|
||||||
2 |
|
6 |
|
||||||
3 |
|
7 |
|
||||||
4 |
|
8 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
Accredo Health Group, Inc. |
|
|
||||||||||||
Liberty Medical Supply, Inc. |
|
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 3 | 5 |
2 | 4 | 6 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 5 | 9 |
2 | 6 | 10 |
3 | 7 | 11 |
4 | 8 | 12 |